ISRCTN90321640已完成不适用
Phyllantus amarus for the protection of liver heath: a randomized controlled trial
Biotropics Malaysia (Malaysia)0 个研究点目标入组 15 人开始时间: 2012年2月23日最近更新:
适应症
试验速览
- 阶段
- 不适用
- 状态
- 已完成
- 发起方
- 入组人数
- 15
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
- 性别
- All
入选标准
- •1. Healthy male or female 21-50 years of age, inclusive
- •2. Subject consumes at least five servings of alcohol per week on a regular basis. Liquor vs wine or beer
- •3. Minimum Profile of Mood States (POMS) score of 15
- •4. Access to a computer and internet
- •5. Subject is willing to maintain his or her habitual food and beverage intake (other than substitution of study food for similar products) and physical activity patterns throughout the study period
- •6. Body mass index (BMI) between 20 and 30 kg/m2
- •7. Subject is willing and able to comply with the alcohol consumption requirements
- •8. Subjects willing to stay in the clinic for two overnight stays
- •9. Generally healthy
- •10. Agree to all visits and study procedures
排除标准
- •1. Any liver condition including hepatitis B, hepatitis C, fatty liver and liver disease
- •2. Liver function greater than three times the upper level limit of normal
- •3. History or record of aggressive or violent behavior
- •4. Evidence of liver disease
- •5. Presence of ascites
- •6. Family history of alcoholism
- •7. Any significant gastrointestinal (GI) condition that would potentially interfere with the evaluation of the study product [e.g.,ulcerative colitis or Crohn?s disease, inflammatory bowel disease, irritable bowel syndrome, clinically significant gastritis, celiac disease, gastroesophageal reflux disease (GERD), history of upper GI bleed (bleeding ulcer), chronic constipation (defined as <3 bowel movements per week), history of frequent diarrhea, history of surgery for weight loss, gastroparesis, clinically important lactose intolerance]
- •8. Clinically significant renal, hepatic, endocrine (including diabetes mellitus), cardiac, pulmonary, pancreatic, neurologic, or biliary disorder
- •9. Known allergy or sensitivity to any ingredients in the study products
- •10. Extreme dietary habits (e.g., vegan, Atkins Diet, etc.)
- •11. Recent (within two weeks of visit 1, week -1) episode of acute gastrointestinal illness such as nausea, vomiting, or diarrhea
- •12. Uncontrolled hypertension (systolic blood pressure _160 mm Hg or diastolic blood pressure _100 mm Hg at visit 1, week -1)
- •13. History or presence of cancer in the prior two years, except for non-melanoma skin cancer
- •14. Any major trauma or surgical event within three months of visit 1, week -1
- •15. Recent use of antibiotics (within 6 weeks)
- •16. Females who are pregnant, lactating, planning to be pregnant during the study period
- •17. Recent history of (within 12 months) or strong potential for alcohol or substance abuse
- •18. Alcohol abuse will be defined as >14 drinks per week (1 drink =12 ounces beer, 5 ounces wine, or 1 ½ ounces distilled spirits)
- •19. Participation in a clinical study with exposure to any non-registered drug product within 30 days prior
- •20. Individual has a condition the Investigator believes would interfere with his or her ability to provide informed consent, comply with the study protocol, which might confound the interpretation of the study results or put the person at undue risk
- •21. Current active respiratory illness at the time of screening
- •22. Any immune system disorders
- •23. Subjects with a history of perforation of the stomach or intestines
- •24. Subjects who have had gastric bypass surgery
- •25. Untreated hypothyroidism
- •26. Subjects with active eating disorder including anorexia nervosa, bulimia, and/or obsessive compulsive eating disorders
- •27. Spinal cord injuries
研究者
相似试验
已完成
2 期
Phyllantus Amarus for the Protection of Liver HealthHealthyNCT03349697Biotropics Malaysia Berhad15
尚未招募
不适用
The Effect of Fortifying the Spleen, Clearing heat, Activating Blood Method on Chronic Atrophic Gastritis: a Real World StudyChronic Atrophic GastritisITMCTR1900002735The First Affiliated Hospital of Guangzhou University of Traditional Chinese Medicine
尚未招募
2 期
Effect of Phyllanthus niruri (Bhumi Amla / keelanelli in tamil) on improving liver functions in patients with liver dysfunction caused by alcohol intakeCTRI/2017/05/008712JIPMER Intramural fund100
招募中
不适用
Herbal supplement to improve liver health in alcoholic persoCTRI/2018/05/013865Composite Interceptive MedScience Laboratories Private Limited
招募中
3 期
Acetylcysteine for the Prevention of Liver Injury in Covid-19 PatientsK72.0Condition 1: COVID-19 pneumonia. Condition 2: Acute liver injury.Pneumonia due to SARS-associated coronavirusAcute and subacute hepatic failureJ12.81IRCT20210726051995N1Artesh University of Medical Sciences88